Background
Methods
Study population and treatment
Statistical analysis
Results
Clinicopathological characteristics
Variables | RNU | PU | t/χ2 | P |
---|---|---|---|---|
Age | 66.74 ± 8.41 | 67.62 ± 10.09 | −0.709 | 0.479 |
Sex | ||||
Male | 90 (49.5%) | 30 (41.4%) | 1.460 | 0.227 |
Female | 92 (50.5%) | 43 (58.9%) | ||
Smoking | ||||
No | 47 (61.8%) | 27 (84.4%) | 5.300 | 0.021 |
Yes | 29 (38.2%) | 5 (15.6%) | ||
Tumor side | ||||
Left | 98 (54.1%) | 29 (39.7%) | 4.325 | 0.038 |
Right | 83 (45.9%) | 44 (60.3%) | ||
Hydronephrosis | ||||
No | 18 (10.3%) | 11 (16.4%) | 1.727 | 0.189 |
Yes | 157 (89.7%) | 56 (83.6%) | ||
Hematuria | ||||
No | 59 (33.7%) | 30 (44.1%) | 2.283 | 0.131 |
Yes | 116 (66.3%) | 38 (55.9%) | ||
Renal function | ||||
Normal | 48 (43.6%) | 20 (47.6%) | 0.195 | 0.659 |
Abnormal | 63 (56.4%) | 22 (52.4%) | ||
Operation time | 157.50 (116.25–180.00) | 95.00 (76.25–126.25) | −4.476 | < 0.001 |
pT stage | 8.287 | 0.067 | ||
pTa | 9 (5.2%) | 2 (3.0%) | ||
pT 1 | 73 (42.0%) | 33 (49.3%) | ||
pT 2 | 48 (27.6%) | 25 (37.3%) | ||
pT 3 | 41 (23.6%) | 6 (9.0%) | ||
pT 4 | 3 (1.7%) | 1 (1.5%) | ||
Lymphovascular invasion | 4 (2.2%) | 0 (0%) | 1.630 | 0.202 |
Oncological outcome
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Age (years) | ||||||
≤ 70 | 1.000 | 1.000 | ||||
> 70 | 0.885 | 0.581–1.348 | 0.569 | 1.240 | 0.488–3.150 | 0.652 |
Sex | ||||||
Male | 1.000 | 1.000 | ||||
Female | 0.713 | 0.478–1.062 | 0.096 | 1.328 | 0.477–3.693 | 0.587 |
Smoking | ||||||
No | 1.000 | 1.000 | ||||
Yes | 1.095 | 0.548–2.190 | 0.797 | 0.695 | 0.225–2.147 | 0.527 |
Tumor side | ||||||
Left | 1.000 | 1.000 | ||||
Right | 0.726 | 0.486–1.084 | 0.117 | 1.136 | 0.451–2.861 | 0.787 |
Hydronephrosis | ||||||
No | 1.000 | 1.000 | ||||
Yes | 1.134 | 0.588–2.188 | 0.707 | 0.742 | 0.149–3.698 | 0.716 |
Hematuria | ||||||
No | 1.000 | 1.000 | ||||
Yes | 1.307 | 0.842–2.029 | 0.233 | 2.405 | 0.820–7.048 | 0.110 |
Renal function | ||||||
Normal | 1.000 | 1.000 | ||||
Abnormal | 1.130 | 0.688–1.911 | 0.650 | 1.503 | 0.613–3.686 | 0.374 |
pT stage | ||||||
pTa–1 | 1.000 | 1.000 | ||||
pT2–4 | 6.907 | 4.028–11.845 | < 0.001 | 9.370 | 2.956–29.697 | < 0.001 |
Surgical intervention | ||||||
RNU | 1.000 | 1.000 | ||||
PU | 1.010 | 0.651–1.567 | 0.964 | 1.705 | 0.608–4.778 | 0.310 |